SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Option Care Health, Inc. – ‘10-Q’ for 3/31/21 – ‘EX-31.1’

On:  Thursday, 5/6/21, at 4:35pm ET   ·   For:  3/31/21   ·   Accession #:  1014739-21-21   ·   File #:  1-11993

Previous ‘10-Q’:  ‘10-Q’ on 11/3/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/3/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 4/23/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/06/21  Option Care Health, Inc.          10-Q        3/31/21   67:4.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    492K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
12: R1          Cover Page                                          HTML     73K 
13: R2          Condensed Consolidated Balance Sheets               HTML    121K 
14: R3          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
15: R4          Unaudited Condensed Consolidated Statements of      HTML     85K 
                Comprehensive Income (Loss)                                      
16: R5          Unaudited Condensed Consolidated Statements of      HTML     21K 
                Comprehensive Income (Loss) (Parenthetical)                      
17: R6          Unaudited Condensed Consolidated Statements of      HTML    109K 
                Cash Flows                                                       
18: R7          Unaudited Condensed Consolidated Statements of      HTML     45K 
                Stockholders? Equity                                             
19: R8          Nature of Operations and Presentation of Financial  HTML     27K 
                Statements                                                       
20: R9          Summary of Significant Accounting Policies          HTML     26K 
21: R10         Revenue                                             HTML     30K 
22: R11         Income Taxes                                        HTML     25K 
23: R12         (Loss) Earnings Per Share                           HTML     29K 
24: R13         Leases                                              HTML     40K 
25: R14         Property and Equipment                              HTML     38K 
26: R15         Goodwill and Other Intangible Assets                HTML     37K 
27: R16         Indebtedness                                        HTML     74K 
28: R17         Derivative Instruments                              HTML     43K 
29: R18         Fair Value Measurments                              HTML     28K 
30: R19         Commitments and Contingencies                       HTML     22K 
31: R20         Stock-Based Incentive Compensation                  HTML     22K 
32: R21         Stockholders' Equity                                HTML     24K 
33: R22         Related-Party Transactions                          HTML     23K 
34: R23         Subsequent Events                                   HTML     21K 
35: R24         Summary of Significant Accounting Policies          HTML     41K 
                (Policies)                                                       
36: R25         Revenue (Tables)                                    HTML     27K 
37: R26         (Loss) Earnings Per Share (Tables)                  HTML     27K 
38: R27         Leases (Tables)                                     HTML     28K 
39: R28         Property and Equipment (Tables)                     HTML     37K 
40: R29         Goodwill and Other Intangible Assets (Tables)       HTML     39K 
41: R30         Indebtedness (Tables)                               HTML     71K 
42: R31         Derivative Instruments (Tables)                     HTML     43K 
43: R32         Nature of Operations and Presentation of Financial  HTML     28K 
                Statements (Details)                                             
44: R33         Summary of Significant Accounting Policies          HTML     47K 
                (Details)                                                        
45: R34         REVENUE - Net Revenue Earned by Category of Payer   HTML     30K 
                (Details)                                                        
46: R35         Income Taxes (Details)                              HTML     28K 
47: R36         (LOSS) EARNINGS PER SHARE - Schedule of Basic and   HTML     46K 
                Diluted Earnings (Details)                                       
48: R37         LEASES - Additional Information (Details)           HTML     27K 
49: R38         LEASES - Maturities of Lease Liabilities (Details)  HTML     37K 
50: R39         Property and Equipment (Details)                    HTML     45K 
51: R40         GOODWILL AND OTHER INTANGIBLE ASSETS - Carrying     HTML     24K 
                Amount of Goodwill (Details)                                     
52: R41         GOODWILL AND OTHER INTANGIBLE ASSETS - Carrying     HTML     37K 
                Amount and Accumulated Amortization of Intangible                
                Assets (Details)                                                 
53: R42         INDEBTEDNESS - Summary of Debt (Details)            HTML     44K 
54: R43         INDEBTEDNESS - Additional Information (Details)     HTML     71K 
55: R44         INDEBTEDNESS - Long Term Debt Maturities (Details)  HTML     36K 
56: R45         INDEBTEDNESS - Estimated Fair Values of Debt        HTML     54K 
                Obligations (Details)                                            
57: R46         DERIVATIVE INSTRUMENTS - Additional Information     HTML     35K 
                (Details)                                                        
58: R47         DERIVATIVE INSTRUMENTS - Balance Sheet Location of  HTML     30K 
                Derivatives (Details)                                            
59: R48         DERIVATIVE INSTRUMENTS - Pre-tax Gain (Loss) on     HTML     33K 
                Derivative Instruments (Details)                                 
60: R49         Stock-Based Incentive Compensation (Details)        HTML     27K 
61: R50         Stockholders' Equity (Details)                      HTML     38K 
62: R51         Related-Party Transactions (Details)                HTML     29K 
63: R52         SUBSEQUENT EVENTS - Narrative (Details)             HTML     23K 
65: XML         IDEA XML File -- Filing Summary                      XML    116K 
11: XML         XBRL Instance -- bios-20210331_htm                   XML    997K 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX     69K 
 7: EX-101.CAL  XBRL Calculations -- bios-20210331_cal               XML    193K 
 8: EX-101.DEF  XBRL Definitions -- bios-20210331_def                XML    400K 
 9: EX-101.LAB  XBRL Labels -- bios-20210331_lab                     XML   1.17M 
10: EX-101.PRE  XBRL Presentations -- bios-20210331_pre              XML    668K 
 6: EX-101.SCH  XBRL Schema -- bios-20210331                         XSD    108K 
66: JSON        XBRL Instance as JSON Data -- MetaLinks              296±   422K 
67: ZIP         XBRL Zipped Folder -- 0001014739-21-000021-xbrl      Zip    199K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 31.1 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John Rademacher, certify that:
1.     I have reviewed this Quarterly Report on Form 10-Q of Option Care Health, Inc.;
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:
(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.     The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 6, 2021


/s/ John Rademacher
John Rademacher
President, Chief Executive Officer and Principal Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/6/218-K
For Period end:3/31/21
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/09/21  Option Care Health, Inc.          424B4                  1:448K                                   Toppan Merrill/FA
 8/05/21  Option Care Health, Inc.          424B4                  1:452K                                   Toppan Merrill/FA
 6/10/21  Option Care Health, Inc.          424B4                  1:447K                                   Toppan Merrill/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/22/21  Option Care Health, Inc.          8-K:1,2,7,9 1/21/21   13:2.3M                                   Toppan Merrill/FA
Top
Filing Submission 0001014739-21-000021   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 4:47:12.2pm ET